Abstract
S4 The Sphingosine 1-Phosphate Receptor Modulator Amiselimod is Efficacious for the Treatment of Active Ulcerative Colitis: Results from a Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have